Trial site
Centre Medico Chirurgical Ambroise Pare Hartmann
- 35running trials
- 16closed trials
The trials here
What the 51 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis21 trials
- Crohn's disease19 trials
- Atrial fibrillation2 trials
- Metastatic breast cancer2 trials
- Aortic stenosis1 trial
- Bladder cancer1 trial
- Colorectal cancer1 trial
- Head and neck cancer1 trial
- Hearing loss1 trial
- Myocarditis1 trial
- Prostate cancer1 trial
- Type 1 diabetes1 trial
- and 1 more
- Phase
- Phase 328 trials
- Phase 216 trials
- Phase 47 trials
- Status
- Recruiting17 trials
- Completed16 trials
- Active, not recruiting11 trials
- Not yet recruiting7 trials
- Lead sponsor
- Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives5 trials
- Janssen Research & Development, LLC5 trials
- AbbVie4 trials
- Abivax S.A.3 trials
- Hoffmann-La Roche3 trials
- and 29 more
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Early Corticosteroids in Severe Influenza Pneumonia, a phase III randomized controlled trial
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Recruiting
A clinical study of MK-7240 for the treatment of Crohn’s disease (MK-7240-008)
Recruiting
Recruiting
Recruiting
Recruiting
Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors
Recruiting
Not yet recruiting
Recruiting
Recruiting
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Study of GS-5290 in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Completed
Active, not recruiting
Effects of ABX464 during long-term treatment in patients with moderate to severe ulcerative colitis
Completed
Recruiting
Active, not recruiting
A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease11 recruiting
- Ulcerative colitis7 recruiting
- Atrial fibrillation2 recruiting
- Aortic stenosis1 recruiting
- Colorectal cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Myocarditis1 recruiting
- Prostate cancer1 recruiting
Closed trials
Completed
Completed
Completed
Completed
A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease
Completed
Completed
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
Completed
SENS-401 to Prevent the Ototoxicity Induced by Cisplatin in Adult Subjects With a Neoplastic Disease
Active, not recruiting
Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis
Completed
Completed
Hydrocorticose and vasopressin in post-resuscitation syndrome
Completed
The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC
Active, not recruiting
Completed
Completed
Active, not recruiting
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026